For the six months, poorer nations asked for only around half a million doses of the AstraZeneca Covishield vaccine produced by the Serum Institute of India, which COVAX had initially regarded as its main supplier.
Photo: AMIT MACHAMASI ollowing initial lab reports that AstraZeneca and VeroCell boosters afford lower or no protection against the new Omicron strain, Nepal Times reached out to Andrew Pollard, who helped develop the Oxford AstraZeneca vaccines. Majority of the vaccinated Nepalis have been administered either with the Chinese VeroCell or the AstraZeneca Covishield manufactured in India. At least […]
AstraZeneca said a rise in profits in the fourth quarter from the Covid-19 vaccine would balance out costs related to developing a Covid-19 antibody treatment, as it kept its overall profit forecast for the year the same.
The final lot of AstraZeneca Covid-19 vaccines donated by Japan to Nepal has arrived in Kathmandu on Monday.
The post Japan Covid-19 vaccine donation to Nepal: Final lot arrives in Kathmandu appeared first on OnlineKhabar English News.
Aug 19: The effectiveness of the Pfizer-BioNTech vaccine against Covid-19 declines faster than that of the AstraZeneca jab, according to a new study published on Thursday.
"Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said.
The study, which has not been peer reviewed, is based on the results of a survey by Britain's Office for National Statistics that carried out PCR tests from December last year to this month on randomly selected households.
It found that "the dynamics of immunity following second doses differed significantly" between Pfizer and AstraZeneca, according to the university's Nuffield Department of Medicine.
Pfizer had "greater initial effectiveness" but saw "faster declines in protection against high viral burden and symptomatic infection", when looking at a period of several months after full vaccination, although rates remained low for both jabs.
"Results suggest that after four to five months effectiveness of these two vaccines would be similar," the scientists added, while stressing that long-term effects need to be studied.
The study's findings come as Israel is administering booster shots, after giving 58 percent of the population two shots of the Pfizer jab.
The United States is also set to offer booster vaccines to boost antibody levels following concerns over declining effectiveness of the Pfizer and Moderna vaccines.
The Oxford research also found that protection was higher among those who had already been infected with the virus.
The study examined two groups of more than 300,000 people over 18, first during the period dominated by the Alpha variant, which emerged in Kent, southeast England, and secondly from May 2021 onwards, when the Delta variant has been dominant.
It confirmed that vaccines are less effective against Delta, which was first seen in India. The AstraZeneca vaccine is the most widely offered in the UK, while those under 40 are offered Pfizer or Moderna due to blood clotting concerns.
Additional 300,000 doses of AstraZeneca Covid-19 vaccines provided by Japan to Nepal on grant arrived in Kathmandu today.
The post Additional 300,000 doses of Covid-19 vaccines arrive from Japan appeared first on OnlineKhabar English News.
Bhutan has delivered 300,000 doses of AstraZeneca Covid-19 vaccines to Nepal as a gift.
The post Bhutan-donated 300,000 doses of AstraZeneca vaccines arrive in Nepal appeared first on OnlineKhabar English News.
A ray of hope for senior citizens above 65 years of age who are waiting for the second dose of the Covishield Covid-19 vaccine for the past few months--Japan is providing some AstraZeneca vaccines to various Asian countries including Nepal.
Photo: UNICEF he United States Embassy in Kathmandu has denied that there is a list of 20 countries that are being considered as potential recipients for its AstraZeneca stockpile. An appeal by The Covid Alliance for Nepal that was carried by Nepali Times on Thursday, and shared widely on social media, had called on Washington […]
Dr Sagar Rajbhandari, director of Sukraraj Tropical and Infectious Disease Hospital, Teku was the first of the frontline workers to receive the jab. Photo: ROSHAN SAPKOTA/RSS epal started vaccinating health and security workers against Covid-19 on Wednesday, using some of the 1 million doses of the AstraZeneca vaccines donated by India on 20 January. Prime […]
After German media outlets said that AstraZeneca's Covid-19 vaccine is not very effective for people over 65, the company has firmly rejected the reports.
The post Efficacy of AstraZeneca on elderly said low by media; company rejects appeared first on The Himalayan Times.
